CAD and cancer: Simultaneous inhibition of uridine salvage with cyclopentenyl uracil and pyrimidine de novo synthesis with the CAD inhibitor PALA increased cancer cell death in mouse models further highlighting the impact of nucleoside salvage on the efficacy of anti-cancer agents targeting de novo synthesis.